IS5691A - Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness - Google Patents

Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness

Info

Publication number: IS5691A
Authority: IS; Iceland
Prior art keywords: treatment; ghs; serm; selective; growth hormone
Prior art date: 1998-06-16

Application number

IS5691A

Other languages

Icelandic (is)

Inventor

Zhu Ke Hua

Li Mei

Codetta Pan Lydia

Duane Thompson David

Original Assignee

Pfizer Products, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-16

Filing date

2000-10-27

Publication date

2000-10-27

2000-10-27 Application filed by Pfizer Products, Inc. filed Critical Pfizer Products, Inc.

2000-10-27 Publication of IS5691A publication Critical patent/IS5691A/en

Links

102000018997 Growth Hormone Human genes 0.000 title 1
108010051696 Growth Hormone Proteins 0.000 title 1
208000010428 Muscle Weakness Diseases 0.000 title 1
206010028372 Muscular weakness Diseases 0.000 title 1
238000011284 combination treatment Methods 0.000 title 1
102000015694 estrogen receptors Human genes 0.000 title 1
108010038795 estrogen receptors Proteins 0.000 title 1
239000000122 growth hormone Substances 0.000 title 1
230000028327 secretion Effects 0.000 title 1
239000000333 selective estrogen receptor modulator Substances 0.000 title 1
229940095743 selective estrogen receptor modulator Drugs 0.000 title 1
210000002027 skeletal muscle Anatomy 0.000 title 1
238000011282 treatment Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Physical Education & Sports Medicine (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IS5691A 1998-06-16 2000-10-27 Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness IS5691A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8946998P	1998-06-16	1998-06-16
PCT/IB1999/001117 WO1999065486A1 (en)	1998-06-16	1999-06-16	Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (1)

Publication Number	Publication Date
IS5691A true IS5691A (en)	2000-10-27

Family

ID=22217825

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5691A IS5691A (en)	1998-06-16	2000-10-27	Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness

Country Status (30)

Country	Link
EP (1)	EP1087764A1 (en)
JP (1)	JP2002518326A (en)
KR (1)	KR20010052852A (en)
CN (1)	CN1301160A (en)
AP (1)	AP9901582A0 (en)
AR (1)	AR018869A1 (en)
AU (1)	AU4054799A (en)
BG (1)	BG105041A (en)
BR (1)	BR9911324A (en)
CA (1)	CA2335134A1 (en)
CO (1)	CO5070587A1 (en)
EA (1)	EA200001186A1 (en)
GT (1)	GT199900087A (en)
HN (1)	HN1999000097A (en)
HR (1)	HRP20000859A2 (en)
HU (1)	HUP0102505A3 (en)
ID (1)	ID27599A (en)
IL (1)	IL138630A0 (en)
IS (1)	IS5691A (en)
MA (1)	MA26652A1 (en)
NO (1)	NO20006312L (en)
OA (1)	OA11505A (en)
PA (1)	PA8475901A1 (en)
PE (1)	PE20000646A1 (en)
PL (1)	PL344981A1 (en)
SK (1)	SK18912000A3 (en)
TN (1)	TNSN99124A1 (en)
TR (1)	TR200003544T2 (en)
WO (1)	WO1999065486A1 (en)
ZA (1)	ZA993975B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2360103A1 (en) *	1999-02-08	2000-08-17	Robert Sladek	Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
DE60124616T2 (en)	2000-05-08	2007-09-13	Pfizer Products Inc., Groton	Enzymatic cleavage of selective modulators of the estrogen receptor
BR0113626A (en)	2000-08-30	2003-06-17	Pfizer Prod Inc	Sustained-Release Formulations for Growth Hormone Secretors
IL145106A0 (en) *	2000-08-30	2002-06-30	Pfizer Prod Inc	Intermittent administration of a geowth hormone secretagogue
US7476653B2 (en)	2003-06-18	2009-01-13	Tranzyme Pharma, Inc.	Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) *	2004-08-31	2006-03-09	Pfizer Products Inc.	Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (en)	2006-02-28	2010-07-20	Ct Ingenieria Genetica Biotech	COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
CN101657436A (en)	2007-02-09	2010-02-24	特兰齐姆制药公司	macrocyclic ghrelin receptor modulators and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA51676C2 (en) *	1995-11-02	2002-12-16	Пфайзер Інк.	(-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition
TW432073B (en) *	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
HN1996000101A (en) *	1996-02-28	1997-06-26	Inc Pfizer	COMBINED THERAPY FOR OSTEOPOROSIS

1999
- 1999-06-15 ZA ZA9903975A patent/ZA993975B/en unknown
- 1999-06-15 AP APAP/P/1999/001582A patent/AP9901582A0/en unknown
- 1999-06-15 AR ARP990102848A patent/AR018869A1/en not_active Application Discontinuation
- 1999-06-15 HN HN1999000097A patent/HN1999000097A/en unknown
- 1999-06-15 PE PE1999000528A patent/PE20000646A1/en not_active Application Discontinuation
- 1999-06-15 PA PA19998475901A patent/PA8475901A1/en unknown
- 1999-06-16 BR BR9911324-4A patent/BR9911324A/en not_active Application Discontinuation
- 1999-06-16 IL IL13863099A patent/IL138630A0/en unknown
- 1999-06-16 WO PCT/IB1999/001117 patent/WO1999065486A1/en not_active Ceased
- 1999-06-16 EA EA200001186A patent/EA200001186A1/en unknown
- 1999-06-16 CN CN99806237A patent/CN1301160A/en active Pending
- 1999-06-16 AU AU40547/99A patent/AU4054799A/en not_active Abandoned
- 1999-06-16 ID IDW20002627A patent/ID27599A/en unknown
- 1999-06-16 GT GT199900087A patent/GT199900087A/en unknown
- 1999-06-16 JP JP2000554366A patent/JP2002518326A/en active Pending
- 1999-06-16 TN TNTNSN99124A patent/TNSN99124A1/en unknown
- 1999-06-16 HU HU0102505A patent/HUP0102505A3/en unknown
- 1999-06-16 CO CO99037622A patent/CO5070587A1/en unknown
- 1999-06-16 EP EP99923802A patent/EP1087764A1/en not_active Withdrawn
- 1999-06-16 HR HR20000859A patent/HRP20000859A2/en not_active Application Discontinuation
- 1999-06-16 KR KR1020007014186A patent/KR20010052852A/en not_active Ceased
- 1999-06-16 CA CA002335134A patent/CA2335134A1/en not_active Abandoned
- 1999-06-16 TR TR2000/03544T patent/TR200003544T2/en unknown
- 1999-06-16 MA MA25628A patent/MA26652A1/en unknown
- 1999-06-16 SK SK1891-2000A patent/SK18912000A3/en unknown
- 1999-06-16 PL PL99344981A patent/PL344981A1/en not_active Application Discontinuation
2000
- 2000-10-20 OA OA1200000290A patent/OA11505A/en unknown
- 2000-10-27 IS IS5691A patent/IS5691A/en unknown
- 2000-12-11 BG BG105041A patent/BG105041A/en unknown
- 2000-12-12 NO NO20006312A patent/NO20006312L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
PE20000646A1 (en)	2000-08-05
TNSN99124A1 (en)	2005-11-10
NO20006312D0 (en)	2000-12-12
KR20010052852A (en)	2001-06-25
CN1301160A (en)	2001-06-27
TR200003544T2 (en)	2001-04-20
AP9901582A0 (en)	1999-06-30
OA11505A (en)	2004-05-07
ZA993975B (en)	2000-12-15
GT199900087A (en)	2000-12-07
AR018869A1 (en)	2001-12-12
MA26652A1 (en)	2004-12-20
SK18912000A3 (en)	2001-10-08
HUP0102505A2 (en)	2001-11-28
IL138630A0 (en)	2001-10-31
BG105041A (en)	2001-08-31
CA2335134A1 (en)	1999-12-23
ID27599A (en)	2001-04-12
HN1999000097A (en)	1999-11-03
EA200001186A1 (en)	2001-06-25
HUP0102505A3 (en)	2002-12-28
EP1087764A1 (en)	2001-04-04
AU4054799A (en)	2000-01-05
PA8475901A1 (en)	2000-05-24
WO1999065486A1 (en)	1999-12-23
BR9911324A (en)	2001-04-03
NO20006312L (en)	2000-12-12
HRP20000859A2 (en)	2001-04-30
CO5070587A1 (en)	2001-08-28
PL344981A1 (en)	2001-11-19
JP2002518326A (en)	2002-06-25

Publication	Publication Date	Title
IS2595B (en)	2010-03-15	Protein blend and process for isolating protein mixture from muscle tissue
DK0881354T3 (en)	2004-04-13	Method and apparatus for cementing a well
GB0116451D0 (en)	2001-08-29	Bone cement mixer and method
DK0946190T3 (en)	2003-12-08	Methods and Compositions for Stimulating Neurite Growth
ATE356139T1 (en)	2007-03-15	DIPEPTIDE DERIVATIVES FOR PROMOTING GROWTH HORMONE SECRETION
NO981426D0 (en)	1998-03-30	Method and apparatus for primary-well cementing
AU6459000A (en)	2001-03-05	Method and apparatus for delivering cement to bones and/or positioning components
HUP0003051A3 (en)	2004-04-28	Method and apparatus for producing cement clinker
DK1181397T3 (en)	2003-11-24	Rhodium electrocatalyst and process for its preparation
DK1021379T3 (en)	2003-08-04	Apparatus for purifying and draining water
NO20010468L (en)	2001-03-27	Use of biogenic estrogen sulfamates for hormone replacement therapy
DK0808577T3 (en)	2003-03-10	Method and apparatus for making aerated frozen products
DK0831098T3 (en)	2002-05-21	Intermediates and process for the preparation of olanzapine
IS5691A (en)	2000-10-27	Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness
DK3497A (en)	1997-07-11	Sustained release formulation of an animal growth hormone and process for its preparation
DK1131083T3 (en)	2004-04-26	Use of growth hormone releasing compounds and antagonists thereof for the treatment of tumors
DK1004583T3 (en)	2004-12-13	Process and hydantoin intermediates for the synthesis of growth hormone secretagogues
DK0911303T4 (en)	2008-01-02	Method and system for controlling mixing of raw materials for cement
IS5719A (en)	2000-11-21	Treatment combinations consisting of selective estrogen receptor modulator and parathyroid hormone
NO20011824D0 (en)	2001-04-10	Controlled release fertilizer mixtures and processes for their preparation
IS5727A (en)	2000-11-24	Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone (GHS) to treat skeletal muscle weakness
GB9913560D0 (en)	1999-08-11	Mixing apparatus and method of mixing
AP9700913A0 (en)	1997-01-31	Establishment of tonic ovarian estrogen secretion for extended therapeutic regiments
DK1031575T3 (en)	2005-01-03	Process for Preparation of Growth Hormone Secretion Inducers
DK0931454T3 (en)	2001-07-23	Apparatus for comminution and mixing of animal feed components